Protective effect of cinnamaldehyde on streptozotocin-induced damage in rat pancreatic β-cells

Food Science and Biotechnology

Volumn 20, Issue 5, 2011, Pages 1271-1276

  Yuan, Hai Dan ^a   Huang, Bo ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

cinnamaldehyde (CNA); nuclear factor (NF) B; RINm5F cell; streptozotocin (STZ)

Indexed keywords

ANTI-INFLAMMATORY ACTIVITY; ANTIDIABETIC; CELL DAMAGE; CELL DYSFUNCTION; CINNAMALDEHYDE; CONCENTRATION-DEPENDENT; CYCLOOXYGENASES; EXTRACELLULAR SIGNAL-REGULATED KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE (INOS); INSULINOMA CELLS; MRNA LEVEL; NUCLEAR FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASE; PROSTAGLANDINE; PROTECTIVE EFFECTS; STREPTOZOTOCIN;

ALDEHYDES; CELLS; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE; LIGHT POLARIZATION; NITRIC OXIDE; PHOSPHORYLATION; RATS;

CYTOLOGY;

CINNAMOMI; CINNAMOMUM VERUM; RATTUS;

EID: 84857542690     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-011-0175-6     Document Type: Article

References (34)

1. Jorns A, Gunther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S. Immune cell infiltration, cytokine expression, and β-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW. 1AR1/Ztm-iddm rat. Diabetes 54: 2041-2052 (2005).
2. Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F. Non-obese-diabetic mice: Immune mechanisms of pancreatic β-cell destruction. Dibetologia 27: 113-115 (1984).
3. Amirshahokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicol. Appl. Pharm. 232: 119-124 (2008).
4. Kwon KB, Kim EK, Jeong ES, Lee YH, Lee YR, Park JW, Ryu DG, Park BH. Cortex cinnamomi extract prevents streptozotocinand cytokine-induced β-cell damage by inhibiting NF-κB. World J. Gastroentero. 12: 4331-4337 (2006).
5. Kim JD, Kang SM, Seo BI, Choi HY, Choi HS, Ku SK. Antidiabetic activity of SMK001, a poly herbal formula in streptozotocin induced diabetic rats: Therapeutic study. Biol. Pharm. Bull. 29: 477-482 (2006).
6. Kwon NS, Lee SH, Choi CS, Kho T, Lee HS. Nitric oxide generation from streptozotocin. FASEB J. 8: 529-533 (1994).
7. Toriizuka K. Basic lecture of Kampo medicine: Pharmacological effect of cinnamon. Kampo Med. 11: 431-436 (1998).
8. Barceloux DG. Cinnamon (Cinnamomum species). pp. 327-335. In: Medical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Toxic Plants, and Venomous Animals. Barceloux DG (ed). John Wiley & Sons, Inc., Hoboken, NJ, USA (2009).
9. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ. Isolation and characterization of polyphenol type-A oligomers from cinnamon with insulin-like biological activity. J. Agr. Food Chem. 52: 65-70 (2004).
10. Chao LK, Hua KF, Hsu HY, Cheng SS, Lin IF, Chen CJ, Chen ST, Chang ST. Cinnamaldehyde inhibits pro-inflammatory cytokines sretion from monocytes/macrophages though suppression of intracellular signaling. Food Chem. Toxicol. 46: 220-231 (2007).
11. Gowder SJ, Devaraj H. Effect of the food flavour cinnamaldehyde on the antioxidant status of rat kidney. Basic Clin. Pharmacol. 99: 379-382 (2006).
12. Pei RS, Zhou F, Ji BP, Xu J. Evaluation of combined antibacterial effects of eugenol, cinnamaldehyde, thymol, and carvacrol against E. coli with an improved method. J. Food Sci. 74: 379-383 (2009).
13. Zhang W, Xu YC, Guo FJ, Meng Y, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chinese Med. J.-Peking 121: 2124-2128 (2008).
14. Reddy AM, Seo JH, Ryu SY, Kim YS, Kim YS, Min KR, Kim Y. Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-κB inhibitors from Cinnamomum cassia. Planta Med. 70: 823-827 (2004).
15. Guo JY, Huo H, Zhao BS, Liu HB, Li LF, Ma YY, Guo SY, Jiang TL. Cinnamaldehyde reduces IL-1β-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells. Eur. J. Pharmacol. 537: 174-180 (2006).
16. 2. Toxicol. Appl. Pharm. 229: 161-171 (2008).
17. Moncada S, Palmer RM. Biosynthesis and action of nitric oxide. Semin. Perinatol. 15: 16-19 (1991).
18. Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCRamplified cDNA fragments. Genomics 11: 124-134 (1991).
19. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res. Clin. Pr. 62: 139-148 (2003).
20. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T. Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr. 40: 163-173 (2007).
21. Khan A, Bryden NA, Polansky MM, Anderson RA. Insulin potentiating factor and chomium content of selected foods and spices. Biol. Trace Elem. Res. 24: 183-188 (1990).
22. Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26: 3215-3218 (2003).
23. Jia Q, Liu X, Wu X, Wang R, Hu X, Li Y, Huang C. Hypoglycemic activity of a polyphenolic oligomer-rich extract of Cinnamomum parthenoxylon bark in normal and streptozotocin-induced diabetic rats. Phytomedicine 16: 744-750 (2009).
24. Kim W, Khil LY, Clark R, Bok SH, Kim EE, Lee S, Jun HS, Yoon JW. Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4. Diabetologia 49: 2437-2448 (2006).
25. Subash BP, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde-A potential antidiabetic agent. Phytomedicine 14: 15-22 (2007).
26. Kim EK, Kwon KB, Song MY, Han MJ, Lee JH, Lee YR, Lee JH, Ryu DG, Park BH, Park JW. Flavonoids protect against cytokine-induced pancreatic β-cell damage though suppression of nuclear factor κB activation. Pancreas 35: 1-9 (2007).
27. Yang F, Bleich D. Transcriptional regulation of cyclooxygenase-2 gene in pancreatic β-cells. J. Biol. Chem. 279: 35403-35411 (2004).
28. 2 production by asiatic acid via NF-κB inactivation in RAW 264. 7 macrophages: Possible involvement of the IKK and MAPK pathways. Int. Immunopharmacol. 8: 431-441 (2008).
29. Baeuerle PA, Baltimore D. NF-κB: Ten years after. Cell 87: 13-20 (1996).
30. Saccani S, Pantano S, Natoli G. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193: 1351-1359 (2001).
31. Karin M. How NF-κB is activated: The role of the IκB kinase (IKK) complex. Oncogene 18: 6867-6874 (1999).
32. Kefaloyianni E, Gaitanaki C, Beis I. ERK1/2 and p38-MAPK signalling pathways, though MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblasts. Cell Signal. 18: 2238-2251 (2006).
33. Pan MH, Lai CS, Wang YJ, Ho CT. Acacetin suppressed LPSinduced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem. Pharmacol. 72: 1293-1303 (2006).
34. Kim YJ, Hwang SY, Oh ES, Oh S, Han IO. IL-1β, an immediate early protein sreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells though p38 MAPK and NF-κB pathways. J. Neurosci. Res. 84: 1037-1046 (2006).